Orion Corp (OTCMKTS:ORINY) – Equities research analysts at Jefferies Group raised their FY2017 EPS estimates for shares of Orion in a note issued to investors on Monday. Jefferies Group analyst J. Vane-Tempest now forecasts that the company will post earnings of $0.98 per share for the year, up from their previous estimate of $0.97. Jefferies Group also issued estimates for Orion’s FY2018 earnings at $0.98 EPS, FY2019 earnings at $0.97 EPS, FY2020 earnings at $0.93 EPS, FY2021 earnings at $0.94 EPS and FY2022 earnings at $1.03 EPS.
Separately, Zacks Investment Research lowered shares of Orion from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th.
Orion Company Profile
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs.
Receive News & Ratings for Orion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion and related companies with MarketBeat.com's FREE daily email newsletter.